2000
DOI: 10.1016/s0741-5214(00)70070-x
|View full text |Cite
|
Sign up to set email alerts
|

Changes in the practice of angioaccess surgery: Impact of dialysis outcome and quality initiative recommendations

Abstract: By adopting the DOQI recommendations, we used NAVFs more often. This resulted in superior patency rates, compared with synthetic grafts. The liberal use of preoperative duplex venous mapping further increased NAVF use, surpassing the DOQI expectations for primary arteriovenous fistulas. Additionally, fewer revisions were required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
132
0
17

Year Published

2003
2003
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 234 publications
(151 citation statements)
references
References 11 publications
2
132
0
17
Order By: Relevance
“…Of these, the native arteriovenous fistula is preferred for long-term hemodialysis vascular access since it has the best long-term primary patency rate, requires the fewest interventions of any type of access, and most importantly, arteriovenous fistulas are associated with the lowest incidence of morbidity and mortality. [3][4][5][6][7] The benefits of arteriovenous fistulas over other forms of chronic access are: Arteriovenous fistulas are associated with decreased morbidity and mortality among hemodialysis patients compared with arteriovenous grafts and central venous catheters. [8][9][10] Arteriovenous fistulas have the superior primary patency rates, the lowest rates of thrombosis, and require the fewest secondary interventions.…”
Section: Introductionmentioning
confidence: 99%
“…Of these, the native arteriovenous fistula is preferred for long-term hemodialysis vascular access since it has the best long-term primary patency rate, requires the fewest interventions of any type of access, and most importantly, arteriovenous fistulas are associated with the lowest incidence of morbidity and mortality. [3][4][5][6][7] The benefits of arteriovenous fistulas over other forms of chronic access are: Arteriovenous fistulas are associated with decreased morbidity and mortality among hemodialysis patients compared with arteriovenous grafts and central venous catheters. [8][9][10] Arteriovenous fistulas have the superior primary patency rates, the lowest rates of thrombosis, and require the fewest secondary interventions.…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5][6][7] The major factor limiting fistula use for dialysis is the high rate of primary failure (fistulas that are never usable for dialysis) due to either early thrombosis or inadequate maturation. 2 The primary failure rate is higher in women than in men and higher in forearm than in upper arm fistulas.…”
mentioning
confidence: 99%
“…In the mid-1990s, the situation was reviewed in the U.S., following the DOQI recommendation, and revival of the autogenous fi stulas took place due to less proneness to stenoses, thromboses and infectious complications in comparison with the grafts. It was recommended that at least 50 % of the fi stulas created was autogenous 2,11 . A summary of the observations of both access types in the U.S. shows that both fi stula types have a comparable operating duration, with the advantage of autogenous fi stulas being the lower number of post-maturity complications and fi stula interventions.…”
Section: Resultsmentioning
confidence: 99%
“…The steal syndrome shows early manifestations in fi stulas performed with a graft as opposed to their later manifestation in autogenous fi stulas in connection with fi stula development 23 . Diabetes mellitus is considered a risk factor for the occurrence of this complication 11,16,[24][25][26][27][28] . However, some authors do not agree 29 .…”
Section: Resultsmentioning
confidence: 99%